Brief: Bellerophon Therapeutics Inc Principal Financial And Accounting Officer Notifies Intent To Resign
25/04/2023 22:28
April 25 (Reuters) - Bellerophon Therapeutics Inc
BLPH.O :
* BELLEROPHON THERAPEUTICS INC - ON APRIL 19, NICHOLAS
LACCONA,
PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER OF CO NOTIFIED CO OF
HIS INTENT TO RESIGN
* BELLEROPHON THERAPEUTICS INC - COMPANY AND MR. LACCONA ARE
CURRENTLY NEGOTIATING THE EFFECTIVE DATE OF HIS RESIGNATION
Source: (https://shorturl.at/tvI25)
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen